FDA’s Current Thinking for Industry cGMPs for Phase 1 INDs 2012
February 14, 2012(Ended)
Online Webinar
The FDA’s Current Thinking for Industry cGMPs for Phase 1 INDs is a course that covers topics such as:
- Scope
- Background and rationale for guidance and proposed regulation
- Recommendations for complying with the statue- personnel,Quality Control Function, facility and Equipment, Control of Components, Production and Documentation, Laboratory Controls,Container Closure and Labeling, Distribution and Record keeping
- CGMP Statutory and Regulatory Requirements
- Biological and Biotechnological Products
- Special production situations
- Sterile products/aseptically processed products
Prices *
249-999 US Dollar
Exhibition
No exhibition
Organization
Categories
Concurrent events
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Articles/News/Press releases
- An Industrial conference as a vital tool to promote an industry
- Mechanisms of hearing loss in prematures and fullterms with perinatal or postnatal hypoxia
- Cancer Basic Research
- Effect Of Traditional Egyptian Herbal Medicine on Treatment of Hepatitis C virus (HCV)
- Validation of Palliative Prognostic Index for Terminal Cancer Patients in Hospice Consultation Setting in Taiwan
- Estimation of Serum Leptin Levels in Patients with chronic hepatitis C (CHC)
